Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-02-16 Major Shareholding Noti…
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
持股5%以上股东权益变动达到5%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in shareholding by a shareholder holding more than 5% of the company's shares. It details the reduction in shares held by Shanghai Tiancong Enterprise Management Center (Limited Partnership) from 6.9892% to 5.0000%. The document includes specifics about the shareholding change, dates, and confirms compliance with relevant securities laws. There is no financial data, earnings information, or management discussion. The content matches the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2025-02-16 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 100% confidence The document is a stock trading abnormal fluctuation announcement by Shanghai Chenguang Medical Technology Co., Ltd. It details the recent abnormal price movement of the company's stock, the investigation into possible causes, confirmation of no undisclosed material information, and a risk warning to investors. It does not contain financial statements, management discussion, or detailed financial results. It is a regulatory announcement related to stock price behavior and compliance with exchange rules, typical of a Regulatory Filing (RNS). The document length is short (985 characters), and it is not an announcement of a report publication but a standalone disclosure. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-02-16 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled "简式权益变动报告书" which translates to "Simplified Equity Change Report." It details the reduction in shareholding by a significant shareholder (information disclosure obligor) in Shanghai Chenguang Medical Technology Co., Ltd. The document includes specifics about the shareholding before and after the change, the method of reduction (centralized bidding), and future plans for share reduction. It references compliance with Chinese securities laws and Beijing Stock Exchange rules. The content is focused on reporting a change in major shareholding stakes rather than financial results, management changes, or other corporate events. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document length (5864 characters) and detailed disclosure confirm it is the report itself, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is MRQ with high confidence.
2025-02-16 Chinese
持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in shareholding by a shareholder holding more than 5% of the company's shares. It details the reduction in shares held by Shanghai Tiancong Enterprise Management Center (Limited Partnership) from 6.9892% to 5.7314%, exceeding a 1% change threshold. The document includes specifics about the shareholding before and after the change, confirms no violation of securities laws, and states that the change does not affect control of the company. This matches the definition of a Major Shareholding Notification (MRQ), which involves notifying changes in significant share ownership levels crossing thresholds. The document is not a full financial report, earnings release, or other types of filings, but a regulatory announcement about shareholding changes.
2025-02-11 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shares held by company insiders and other shareholders. It details the number of shares becoming tradable, the shareholders involved, and the reasons for lifting the restrictions. This is a capital-related update about share status and trading eligibility, not a financial report or earnings release. It does not contain financial statements or management discussion but is a formal disclosure about share capital changes related to restricted shares becoming unrestricted. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is short and focused on this specific capital event, confirming the classification.
2025-02-06 Chinese
关于公司取得《医疗器械注册证》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Chenguang Medical Technology Co., Ltd. about obtaining a Medical Device Registration Certificate issued by the Shanghai Drug Administration. It details the certificate number, product specifications, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no shareholder voting, no management changes, or other financial report types. The document is a regulatory announcement about a certification related to product registration, not a financial or governance report. It is a regulatory announcement that does not fit into other specific categories, so it falls under Regulatory Filings (RNS). The document length is short and it is a standalone announcement, not a report or presentation.
2025-01-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.